Resultados de la búsqueda
Sánchez-Cabo F, Fuster JJ Clonal haematopoiesis and atherosclerosis: a chicken or egg question? Nat Rev Cardiol (2021) 18:463-464
Fuster JJ, Zuriaga MA, Zorita V, MacLauchlan S, Polackal MN, Viana-Huete V, Ferrer-Perez A, Matesanz N, Herrero-Cervera A, Sano S, Cooper MA, Gonzalez-Navarro H, Walsh K TET2-Loss-of-Function-Driven Clonal Hematopoiesis Exacerbates Experimental Insulin Resistance in Aging and Obesity Cell Rep (2020) 33:108326
Link to the full text in Repisalud
Link to the full text in Repisalud
Amoros-Perez M, Fuster JJ Clonal hematopoiesis driven by somatic mutations: A new player in atherosclerotic cardiovascular disease Atherosclerosis (2020) 297:120-6
Wang Y, Sano S, Yura Y, Ke Z, Sano M, Oshima K, Ogawa H, Horitani K, Min KD, Miura-Yura E, Kour A, Evans MA, Zuriaga MA, Hirschi KK, Fuster JJ, Pietras EM, Walsh K Tet2-mediated clonal hematopoiesis in non-conditioned mice accelerates age-associated cardiac dysfunction JCI Insight (2020) 5:135204
Fuster JJ. Integrated Stress Response Inhibition in Atherosclerosis: Preventing the Stressed-Out Plaque. J Am Coll Cardiol (2019) 73:1170-2
Khetarpal SA, Qamar A, Bick AG, Fuster JJ, Kathiresan S, Jaiswal S, Natarajan P. Clonal Hematopoiesis of Indeterminate Potential Reshapes Age-Related CVD: JACC Review Topic of the Week. J Am Coll Cardiol (2019) 74:578-86
Viana-Huete V, Fuster JJ. Potential therapeutic value of interleukin 1beta-targeted strategies in atherosclerotic cardiovascular disease. Rev Esp Cardiol (2019) 72:760-6
Fuster JJ*, MacLauchlan S, Zuriaga MA, Polackal MN, Ostriker AC, Chakraborty R, Wu C-L, Sano S, Muralidharan S, Rius C, Vuong J, Jacob S, Muralidhar V, Robertson AAB, Cooper MA, Andres V, Hirschi KK, Martin KA, Walsh K* (JJF and KW are co-corresponding authors). Clonal hematopoiesis associated with Tet2 deficiency accelerates atherosclerosis development in mice. Science (2017) 355:842-7
Link to the full text in Repisalud
Link to the full text in Repisalud